New Risk • Jul 02
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩15.1b (US$9.74m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 7.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (32% increase in shares outstanding). Market cap is less than US$10m (₩15.1b market cap, or US$9.74m). Board Change • Apr 29
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. New Risk • Apr 05
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 32% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (32% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩28.7b market cap, or US$19.0m). Reported Earnings • Mar 21
Full year 2025 earnings released: ₩16.00 loss per share (vs ₩527 loss in FY 2024) Full year 2025 results: ₩16.00 loss per share (improved from ₩527 loss in FY 2024). Revenue: ₩53.2b (up ₩47.5b from FY 2024). Net loss: ₩813.3m (loss narrowed 95% from FY 2024). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 35% per year, which means it is significantly lagging earnings. Tillkännagivande • Mar 11
Alticast Corporation, Annual General Meeting, Mar 24, 2026 Alticast Corporation, Annual General Meeting, Mar 24, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 322, nonhyeon-ro, gangnam-gu, seoul South Korea Tillkännagivande • Sep 09
Alticast Corporation (KOSDAQ:A085810) agreed to acquire an 8.07% stake in Aptamer Sciences Inc (KOSDAQ:A291650) from Han Dong-il, Ryu Seong-ho, Jang Seung-gi for KRW 4.4 billion. Alticast Corporation (KOSDAQ:A085810) agreed to acquire an 8.07% stake in Aptamer Sciences Inc (KOSDAQ:A291650) from Han Dong-il, Ryu Seong-ho, Jang Seung-gi for KRW 4.4 billion on September 8, 2025. Alticast Corporation will pay Aptamer Sciences Inc KRW 1800 per share. The expected completion of the transaction is October 27, 2025. New Risk • Aug 30
New minor risk - Financial data availability Less than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (70% increase in shares outstanding). Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (₩30.9b market cap, or US$22.3m). Tillkännagivande • Mar 27
Alticast Corporation (KOSDAQ:A085810) agreed to acquire 81.84% stake in Daihyun Eng & Const Co., Ltd. from Cho Hon Gu and 8 others for KRW 18.0 billion. Alticast Corporation (KOSDAQ:A085810) agreed to acquire 81.84% stake in Daihyun Eng & Const Co., Ltd. from Cho Hon Gu and 8 others for KRW 18.0 billion on March 26, 2025. A cash consideration of KRW 18 billion will be paid by Alticast Corporation for 65,475 shares. The expected completion of the transaction is April 11, 2025. Reported Earnings • Mar 22
Full year 2024 earnings released: ₩527 loss per share (vs ₩678 loss in FY 2023) Full year 2024 results: ₩527 loss per share (improved from ₩678 loss in FY 2023). Revenue: ₩5.68b (flat on FY 2023). Net loss: ₩15.6b (loss narrowed 20% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 32% per year whereas the company’s share price has fallen by 33% per year. Tillkännagivande • Mar 13
Alticast Corporation, Annual General Meeting, Mar 26, 2025 Alticast Corporation, Annual General Meeting, Mar 26, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 322, nonhyeon-ro, gangnam-gu, seoul South Korea Tillkännagivande • Jan 21
BENO TNR, Inc. (KOSDAQ:A206400) and Pentashield No. 1 Association completed the acquisition of 32.16% stake in Alticast Corporation (KOSDAQ:A085810) from Humax Co., Ltd. (KOSDAQ:A115160). BENO TNR, Inc. (KOSDAQ:A206400) and Pentashield No. 1 Association agreed to acquire 32.16% stake in Alticast Corporation (KOSDAQ:A085810) from Humax Co., Ltd. (KOSDAQ:A115160) for KRW 6.5 billion on December 13, 2024. As part of the acquisition, Pentashield No. 1 Association and BENO TNR, Inc will acquire 24.13% and 8.03% respectively. A cash consideration valued at KRW 650 per share will be paid by BENO TNR, Inc. and Pentashield No. 1 Association. BENO TNR, Inc. and Pentashield No. 1 Association will acquire 24.13% stake and 8.03% stake in Alticast Corporation respectively. The expected completion of the transaction is January 21, 2025.
BENO TNR, Inc. (KOSDAQ:A206400) and Pentashield No. 1 Association completed the acquisition of 32.16% stake in Alticast Corporation (KOSDAQ:A085810) from Humax Co., Ltd. (KOSDAQ:A115160) on January 21, 2025. The consideration consists of KRW 1.3 billion was paid as deposit on December 13, 2024 and remaining KRW 5.2 billion on January 21, 2025. New Risk • Oct 22
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 23% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Revenue is less than US$5m (₩6.0b revenue, or US$4.4m). Market cap is less than US$100m (₩39.5b market cap, or US$28.6m). Tillkännagivande • Oct 10
An undisclosed buyer agreed to acquire an unknown minority stake in Alticast Corporation (KOSDAQ:A085810) from Humax Co., Ltd. (KOSDAQ:A115160) for KRW 15.0 billion. An undisclosed buyer agreed to acquire an unknown minority stake in Alticast Corporation (KOSDAQ:A085810) from Humax Co., Ltd. (KOSDAQ:A115160) for KRW 15.0 billion on October 8, 2024. Tillkännagivande • Oct 09
Alticast Corporation announced that it expects to receive KRW 10.000001035 billion in funding Alticast Corporation announced a private placement to issue 8,285,005 common shares at an issue price of KRW 1,207 per share for the gross proceeds of KRW 10,000,001,035 on October 8, 2024. The transaction will include participation from new investor Solid Trust Fund No. 1. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on December 5, 2024. New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Market cap is less than US$100m (₩30.1b market cap, or US$22.8m). New Risk • Aug 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩2.7b free cash flow). Earnings have declined by 25% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Revenue is less than US$5m (₩6.0b revenue, or US$4.4m). Market cap is less than US$100m (₩30.3b market cap, or US$22.1m). Reported Earnings • Mar 26
Full year 2023 earnings released: ₩899 loss per share (vs ₩556 loss in FY 2022) Full year 2023 results: ₩899 loss per share (further deteriorated from ₩556 loss in FY 2022). Revenue: ₩6.23b (down 14% from FY 2022). Net loss: ₩26.0b (loss widened 62% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance. New Risk • Nov 29
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩8.7b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩8.7b free cash flow). Earnings have declined by 27% per year over the past 5 years. Minor Risks Revenue is less than US$5m (₩6.3b revenue, or US$4.9m). Market cap is less than US$100m (₩35.3b market cap, or US$27.3m). Is New 90 Day High Low • Mar 08
New 90-day low: ₩1,720 The company is down 32% from its price of ₩2,535 on 08 December 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 5.0% over the same period. Is New 90 Day High Low • Jan 29
New 90-day low: ₩1,745 The company is down 22% from its price of ₩2,235 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 14% over the same period. Is New 90 Day High Low • Dec 28
New 90-day low: ₩1,765 The company is down 24% from its price of ₩2,315 on 29 September 2020. The South Korean market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 5.0% over the same period. Is New 90 Day High Low • Nov 13
New 90-day high: ₩2,990 The company is up 43% from its price of ₩2,090 on 14 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 7.0% over the same period. Is New 90 Day High Low • Oct 06
New 90-day high: ₩2,445 The company is up 43% from its price of ₩1,705 on 08 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 14% over the same period.